PRECISEMOL LLP

In their own words

PreciseMol represents an innovation-driven specialty chemistry startup that integrates deep scientific expertise with regulatory-focused execution. The core innovation lies in its ability to deliver end-to-end solutions across pharmaceutical impurity chemistry, natural product–based nutraceuticals, and new chemical entity (NCE) development. Unlike conventional suppliers, PreciseMol specializes in the synthesis of structurally complex, late-stage, and first-time impurities, including ND-SRIs, metabolites, and isotope-labeled compounds, which are critical for global regulatory submissions. The startup further differentiates itself by developing non-infringing and, where applicable, patentable synthetic routes, reducing intellectual property risk for clients. In the nutraceutical domain, PreciseMol applies pharmaceutical-grade chemistry and process control to natural products—covering isolation, semi-synthesis, enrichment, and validation—thereby improving consistency, scalability, and regulatory acceptability. Additionally, the startup provides custom synthesis of NCEs with process development, optimization, scale-up, and validation aligned with cGMP and ICH principles. This integrated approach bridges the gap between discovery chemistry and scalable, compliant manufacturing. The innovation of PreciseMol lies not in a single product, but in its platform-driven capability to solve complex chemical and regulatory challenges through science-led customization, speed, and quality—positioning it as a globally competitive Indian innovation enterprise.

Written by the company on its public Startup India profile. Not verified by us.